Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2012
10/18/2012WO2012139736A1 Pharmaceutical composition comprising bosentan
10/18/2012WO2012139521A1 Traditional chinese medicinal composition for preventing and treating influenza a and preparation method therefor and use thereof
10/18/2012WO2012139485A1 Oral solid preparation of compound antituberculosis drug and preparation method thereof
10/18/2012WO2012139424A1 Crystalline forms of tebipenem, preparation methods and uses thereof in the preparation of medicines
10/18/2012WO2012139262A1 Sustained-release preparation of compound methoxyphenamine
10/18/2012WO2012139223A1 System and method for multiphasic release of growth factors
10/18/2012WO2012139190A1 Multilayered films for the controlled release of volatile substances adsorbed in a solid substrate, and use thereof
10/18/2012WO2012102799A3 Method, composition and package for bowel cleansing
10/18/2012WO2012100043A3 Controlled release oral pharmaceutical dosage forms comprising mgbg
10/18/2012WO2012097978A3 Pharmaceutical compositions of immunosuppressants
10/18/2012WO2012097264A3 Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
10/18/2012WO2012096939A3 Highly concentrated liquid acetaminophen solutions
10/18/2012WO2012093973A3 Compositions in the form of tablets comprising acarbose
10/18/2012WO2012091372A3 Caffeine tape for body slimming
10/18/2012WO2012031175A8 Nanoparticle-based tumor-targeted drug delivery
10/18/2012WO2012028526A3 Tetranectin-apolipoprotein a-i, lipid particles containing it and its use
10/18/2012US20120266328 Celluloytic enzymes, nucleic acids encoding them and methods for making and using them
10/18/2012US20120265300 Aligned Fibrous Materials With Spatially Varying Fiber Orientation and Related Methods
10/18/2012US20120265158 Transdermal Patch Formulation
10/18/2012US20120265129 Methods for Chronic Pain Management and Treatment using HCG
10/18/2012US20120265065 Automatic Liquid Injection System and Method
10/18/2012US20120265001 Composite magnetic nanoparticle drug delivery system
10/18/2012US20120264966 Sulfur-containing phospholipid derivatives
10/18/2012US20120264834 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
10/18/2012US20120264833 Pharmaceutical compositions with enhanced performance
10/18/2012US20120264767 Stable pharmaceutical composition of freeze-dried tetrodotoxin powder
10/18/2012US20120264691 Medical compositions containing ghrelin
10/18/2012US20120264676 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
10/18/2012US20120264608 Method for Improving the Aqueous Solubility of Poorly-Soluble Substances
10/18/2012US20120263865 Dual lane coating
10/18/2012US20120263795 Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters
10/18/2012US20120263794 Treatment of eye diseases using encapsulated cells encoding and secreting a neuroprotective factor and/or an anti-angiogenic factor
10/18/2012US20120263793 Bio-nano-plasmonic elements and platforms
10/18/2012US20120263792 Dual drug dosage forms with improved separation of drugs
10/18/2012US20120263791 Fomulation comprising 1 h-quinazoline-2, 4-dione ampa receptor antagonists, in the form of immediate release tablets and preparation thereof
10/18/2012US20120263790 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/18/2012US20120263789 Delayed release rasagiline formulation
10/18/2012US20120263788 Controlled release hydrocodone formulations
10/18/2012US20120263787 Method and apparatus for sealing medicinal capsules
10/18/2012US20120263786 Pharmaceutical Formulations Containing an SGLT2 Inhibitor
10/18/2012US20120263785 Stable cannabinoid compositions and methods for making and storing them
10/18/2012US20120263784 Emergency contraceptive
10/18/2012US20120263783 Single molecule nucleic acid nanoparticles
10/18/2012US20120263782 Methods and compositions for treating hiv infection
10/18/2012US20120263781 Methods and compositions for treating rhinitis
10/18/2012US20120263780 Carbohydrate Entrapped Active Agent Delivery Composition and Articles Using the Same
10/18/2012US20120263779 Biodegradable drug delivery system
10/18/2012US20120263778 Polyurethane urea for stent coatings
10/18/2012US20120263770 Anti-atopic dermatitis textiles
10/18/2012US20120263766 Formulations
10/18/2012US20120263765 Agents from cells
10/18/2012US20120263764 Compositions and methods for inhibiting and/or modulating effector t-cells involved in inflammatory neurodegenerative disease
10/18/2012US20120263763 Regenerative materials
10/18/2012US20120263762 Stabilised particles comprising 5-methyl-(6s)-tetrahydrofolate
10/18/2012US20120263761 Shelf stable pharmaceutical depot
10/18/2012US20120263760 Novel formulation of metaxalone
10/18/2012US20120263759 Coating Comprising An Elastin-Based Copolymer
10/18/2012US20120263747 Albumin-Fused Anti-Angiogenesis Peptides
10/18/2012US20120263666 Topical skin care composition
10/18/2012US20120263655 Combination of medicaments for the treatment of respiratory diseases
10/18/2012US20120263653 Methods and systems for generating nanoparticles
10/18/2012US20120263651 Single Stranded DNA Aptamers Binding NF-kB/RelA
10/18/2012DE102010056029B4 Wärmekompresse und deren Verwendung Heat dressing and their use
10/18/2012CA2833276A1 Encapsulation system for protection of probiotics during processing
10/18/2012CA2833144A1 Multilayer thin film drug delivery device and methods of making and using the same
10/18/2012CA2833105A1 Oral pharmaceutical dispersion compositions
10/18/2012CA2833101A1 Febuxostat solid dispersion
10/18/2012CA2833023A1 System and method for multiphasic release of growth factors
10/18/2012CA2832933A1 Methods for treating bacterial infection
10/18/2012CA2832910A1 Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
10/18/2012CA2832858A1 Solid pharmaceutical composition
10/18/2012CA2832715A1 Dual lane coating
10/18/2012CA2832410A1 Freeze dried drug nanosuspensions
10/18/2012CA2832203A1 Unit dose form for oral administration
10/18/2012CA2830896A1 Aqueous ophthalmic composition
10/17/2012EP2510950A1 Dry-coated orally disintegrating tablet
10/17/2012EP2510926A1 Use of saturated amines compounds in manufacture of medicaments for mobilizing peripheral blood hematopoietic stem cell
10/17/2012EP2510924A1 Solid dispersions containing 20-o- -d-glucopyranosyl-20(s)-protopanaxadiol
10/17/2012EP2510923A1 Coating composition, solid preparation coated therewith, and method for preparing solid preparation
10/17/2012EP2510922A1 Manufacturing process for tablet formulations comprising cefuroxime
10/17/2012EP2510921A1 Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer
10/17/2012EP2509643A2 Polyurethane dispersions for sealing the teats of the mammary glands in milking animals
10/17/2012EP2509635A2 Gastric retentive pharmaceutical compositions for extended release of polypeptides
10/17/2012EP2509633A2 Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt)
10/17/2012EP2509632A2 Glycerine based jelly compositions
10/17/2012EP2509631A1 Ph sensitive compounds in taste masking within oral thin film strips
10/17/2012EP2509622A2 Inhibiting bacterial infection and biofilm formation
10/17/2012EP2509596A2 Compounds and methods of treating ocular disorders
10/17/2012EP2509588A1 Stable fat-soluble active principle particles
10/17/2012EP2509587A2 Partial dip coating of dosage forms for modified release
10/17/2012EP2509586A1 Mucoadhesive buccal tablets for the treatment of orofacial herpes
10/17/2012EP2509585A1 Process and product
10/17/2012EP2509584A1 Pharmaceutical composition for treating cutaneous burns
10/17/2012EP2509583A2 Pharmaceutical composition comprising oligopeptides, preferably cilengitide
10/17/2012EP2509582A1 Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof
10/17/2012EP2509568A2 Skin care compositions
10/17/2012EP2509431A1 Balanced fat composition and use thereof in a liquid nutritional composition suitable for enteral feeding
10/17/2012EP1631255B1 Drug delivery system
10/17/2012CN202490188U Micro-capsule implant
10/17/2012CN1927183B Antineoplasma medicine pidorubicin slow release microsphere preparation and method for preparing same
1 ... 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 ... 2991